Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Sale of 20,614 XGN shares, $148.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | EXAGEN INC. (XGN) | Sale | 20,614 | $148.8K |
| Mar 16, 2026 | EXAGEN INC. (XGN) | Grant/Award | 75,000 | $237.0K |
| Feb 26, 2026 | EXAGEN INC. (XGN) | Sale | 1,584 | $5.7K |
| Sep 4, 2025 | EXAGEN INC. (XGN) | Sale | 20,466 | $200.4K |
| Feb 26, 2025 | EXAGEN INC. (XGN) | Grant/Award | 15,000 | n/a |
| Nov 20, 2024 | EXAGEN INC. (XGN) | Purchase | 22,298 | $66.4K |
| Sep 5, 2024 | STANDARD BIOTOOLS INC. (LAB) | Tax Withholding | 6,690 | $12.8K |
| Sep 4, 2024 | EXAGEN INC. (XGN) | Grant/Award | 225,000 | n/a |
| Aug 19, 2024 | STANDARD BIOTOOLS INC. (LAB) | Exercise/Conversion | 13,157 | n/a |
| May 21, 2024 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 300,000 | n/a |